Clinical Trial

Menier's Disease - Bone Density Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Meniere's disease is a progressive and debilitating inner ear disease characterised by vertigo and hearing loss. Several studies have linked Menierws disease with lower bone density and lower vitamin D levels. In the current prospective study definite Meniere's patients will be followed over a period of 2 year, during which repetitive measurements of bone density, vitamin D plasma levels, blood pressure as well as hearing and vestibular tests will be made. Results will be compared to healthy controls.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-04-03.
Trial Details
NCT Number NCT05322538
Lead Sponsor HaEmek Medical Center, Israel
Conditions Meniere Disease, Osteoporosis, Osteopenia, Vitamin D Deficiency, Vestibular Disorder
Enrollment 60 participants
Start Date 2022-10-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-08-03